Literature DB >> 32727872

In Vitro Quantification of the Effects of IP6 and Other Small Polyanions on Immature HIV-1 Particle Assembly and Core Stability.

Alžběta Dostálková1, Filip Kaufman1, Ivana Křížová1, Barbora Vokatá2, Tomáš Ruml2, Michaela Rumlová3.   

Abstract

Proper assembly and disassembly of both immature and mature HIV-1 hexameric lattices are critical for successful viral replication. These processes are facilitated by several host-cell factors, one of which is myo-inositol hexaphosphate (IP6). IP6 participates in the proper assembly of Gag into immature hexameric lattices and is incorporated into HIV-1 particles. Following maturation, IP6 is also likely to participate in stabilizing capsid protein-mediated mature hexameric lattices. Although a structural-functional analysis of the importance of IP6 in the HIV-1 life cycle has been reported, the effect of IP6 has not yet been quantified. Using two in vitro methods, we quantified the effect of IP6 on the assembly of immature-like HIV-1 particles, as well as its stabilizing effect during disassembly of mature-like particles connected with uncoating. We analyzed a broad range of molar ratios of protein hexamers to IP6 molecules during assembly and disassembly. The specificity of the IP6-facilitated effect on HIV-1 particle assembly and stability was verified by K290A, K359A, and R18A mutants. In addition to IP6, we also tested other polyanions as potential assembly cofactors or stabilizers of viral particles.IMPORTANCE Various host cell factors facilitate critical steps in the HIV-1 replication cycle. One of these factors is myo-inositol hexaphosphate (IP6), which contributes to assembly of HIV-1 immature particles and helps maintain the well-balanced metastability of the core in the mature infectious virus. Using a combination of two in vitro methods to monitor assembly of immature HIV-1 particles and disassembly of the mature core-like structure, we quantified the contribution of IP6 and other small polyanion molecules to these essential steps in the viral life cycle. Our data showed that IP6 contributes substantially to increasing the assembly of HIV-1 immature particles. Additionally, our analysis confirmed the important role of two HIV-1 capsid lysine residues involved in interactions with IP6. We found that myo-inositol hexasulphate also stabilized the HIV-1 mature particles in a concentration-dependent manner, indicating that targeting this group of small molecules may have therapeutic potential.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; IP6; assembly; capsid; immature; mature; polyanion

Year:  2020        PMID: 32727872      PMCID: PMC7527058          DOI: 10.1128/JVI.00991-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Modulation of HIV-like particle assembly in vitro by inositol phosphates.

Authors:  S Campbell; R J Fisher; E M Towler; S Fox; H J Issaq; T Wolfe; L R Phillips; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  The stoichiometry of Gag protein in HIV-1.

Authors:  John A G Briggs; Martha N Simon; Ingolf Gross; Hans-Georg Kräusslich; Stephen D Fuller; Volker M Vogt; Marc C Johnson
Journal:  Nat Struct Mol Biol       Date:  2004-06-20       Impact factor: 15.369

3.  Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.

Authors:  Akash Bhattacharya; Steven L Alam; Thomas Fricke; Kaneil Zadrozny; Jaroslaw Sedzicki; Alexander B Taylor; Borries Demeler; Owen Pornillos; Barbie K Ganser-Pornillos; Felipe Diaz-Griffero; Dmitri N Ivanov; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-17       Impact factor: 11.205

4.  The structure and flexibility of conical HIV-1 capsids determined within intact virions.

Authors:  Simone Mattei; Bärbel Glass; Wim J H Hagen; Hans-Georg Kräusslich; John A G Briggs
Journal:  Science       Date:  2016-12-16       Impact factor: 47.728

5.  The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Authors:  Daniel Melamed; Michal Mark-Danieli; Michal Kenan-Eichler; Osnat Kraus; Asher Castiel; Nihay Laham; Tal Pupko; Fabian Glaser; Nir Ben-Tal; Eran Bacharach
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics.

Authors:  Gongpu Zhao; Juan R Perilla; Ernest L Yufenyuy; Xin Meng; Bo Chen; Jiying Ning; Jinwoo Ahn; Angela M Gronenborn; Klaus Schulten; Christopher Aiken; Peijun Zhang
Journal:  Nature       Date:  2013-05-30       Impact factor: 49.962

7.  Inositol phosphates compete with nucleic acids for binding to bovine leukemia virus matrix protein: implications for deltaretroviral assembly.

Authors:  Dominic F Qualley; Crystal M Lackey; Justin P Paterson
Journal:  Proteins       Date:  2013-06-13

8.  The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.

Authors:  A Borsetti; A Ohagen; H G Göttlinger
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity.

Authors:  Martin Obr; Romana Hadravová; Michal DoleŽal; Ivana KříŽová; Veronika Papoušková; Lukáš Zídek; Richard Hrabal; Tomáš Ruml; Michaela Rumlová
Journal:  Retrovirology       Date:  2014-10-30       Impact factor: 4.602

10.  The maturational refolding of the β-hairpin motif of equine infectious anemia virus capsid protein extends its helix α1 at capsid assembly locus.

Authors:  Kang Chen; Grzegorz Piszczek; Carol Carter; Nico Tjandra
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

View more
  11 in total

Review 1.  Insights into HIV uncoating from single-particle imaging techniques.

Authors:  Margaret J Zhang; Jeffrey H Stear; David A Jacques; Till Böcking
Journal:  Biophys Rev       Date:  2022-01-11

2.  The Present and Future of Virology in the Czech Republic-A New Phoenix Made of Ashes?

Authors:  Tomas Ruml
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

3.  Inositol Hexakisphosphate (IP6) Accelerates Immature HIV-1 Gag Protein Assembly toward Kinetically Trapped Morphologies.

Authors:  Alexander J Pak; Manish Gupta; Mark Yeager; Gregory A Voth
Journal:  J Am Chem Soc       Date:  2022-06-06       Impact factor: 16.383

Review 4.  Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.

Authors:  Morganne Wilbourne; Peijun Zhang
Journal:  Viruses       Date:  2021-02-04       Impact factor: 5.818

5.  Effect of Small Polyanions on In Vitro Assembly of Selected Members of Alpha-, Beta- and Gammaretroviruses.

Authors:  Alžběta Dostálková; Barbora Vokatá; Filip Kaufman; Pavel Ulbrich; Tomáš Ruml; Michaela Rumlová
Journal:  Viruses       Date:  2021-01-18       Impact factor: 5.048

Review 6.  Inositol Phosphates and Retroviral Assembly: A Cellular Perspective.

Authors:  Clifton L Ricaña; Robert A Dick
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

7.  Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency.

Authors:  Daniel Poston; Trinity Zang; Paul Bieniasz
Journal:  Retrovirology       Date:  2021-08-28       Impact factor: 4.602

Review 8.  HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.

Authors:  Akatsuki Saito; Masahiro Yamashita
Journal:  Retrovirology       Date:  2021-10-26       Impact factor: 4.602

9.  Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication.

Authors:  Paige R Gruenke; Rachna Aneja; Sarah Welbourn; Obiaara B Ukah; Stefan G Sarafianos; Donald H Burke; Margaret J Lange
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 19.160

Review 10.  Relationship between HIV-1 Gag Multimerization and Membrane Binding.

Authors:  Christopher Sumner; Akira Ono
Journal:  Viruses       Date:  2022-03-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.